Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 77–77 | Cite as

Bortezomib/dexamethasone/lenalidomide

Neuropathy and cytopenia: 2 case reports
Case report
  • 36 Downloads

Reference

  1. Hussaini S, et al. Weekly dosing of bortezomib in rvd achieves minimal toxicity with no reduction in efficacy in a diverse cohort of multiple myeloma patients. Blood 130 (Suppl. 1): 5425, Dec 2017 [abstract] - USAGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations